BeStock  
Stocks › Biotechnology › BCAX

Bicara Therapeutics BCAX

US equityMarket cap rank #3186Biotechnology
$16.42 −$0.14 (-0.85%)
Pre-market · Oct 8, 8:20 am ET · After hours $16.42 0.00%
Open$16.44
Prev close$16.56
Day range$16.25 – $17.11
Volume915.6K
Market cap$1.09B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-5.3x
CheapRich

Near the top of its 5-year range · 98th percentile, 5-year average -9.7x

Price / book2.3x
CheapRich

Above its usual level · 64th percentile, 5-year average 1.4x

#3227 of 5317 stocks by PB (1 = cheapest)

P/E over five years

-22x-14x-6x2xSep '24Sep '25Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$17.76
Price vs. fair value-7.5%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 2.32 – 1.38 64% (pricier than usual) #3227 of 5317 (1 = cheapest)
PE -5.35 -4.22 -9.74 98% (pricier than usual) –
PS – – 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$17.76
Economic moatNone
UncertaintyVery High

Discussion

No comments yet — be the first to weigh in on BCAX.

Leave a comment

Scroll to Top